Please try another search
For the six months ended 30 June 2013, EastonPharmaceuticals Inc revenues was not reported. Net lossincreased from $36K to $84K. Higher net loss reflectsConsulting fees increase from $0K to $25K (expense),Product development increase of 37% to $48K (expense),Transfer agent fees increase from $0K to $3K (expense).
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -0.06 | -0.02 | -0.02 | -0.06 |
Net Income | -0.06 | -0.02 | -0.02 | -0.06 |
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
---|---|---|---|---|
Total Assets | 0.68 | 0.69 | 0.7 | 0.55 |
Total Liabilities | 0.59 | 0.56 | 0.55 | 0.61 |
Total Equity | 0.08 | 0.12 | 0.15 | -0.06 |
Period Ending: | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -0.12 | -0 | -0.01 | -0.07 |
Cash From Investing Activities | 0 | 0 | 0 | |
Cash From Financing Activities | 0.12 | 0 | 0.01 | 0.07 |
Net Change in Cash | 0 | -0 | 0 | 0 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review